You save $69.98
CISSP Premium Bundle
- Premium File 484 Questions & Answers
- Last Update: Oct 31, 2026
- Training Course 62 Lectures
- Study Guide 2003 Pages
You save $69.98
A scanner lists many possible CVEs across public hosts. Executives call the report evidence that attackers can compromise customer records. What assessment approach BEST substantiates or corrects the claim?
A scanner match is not proof of exploitation; a scoped penetration test can demonstrate feasible attack paths, while continued scanning is needed for broader coverage.
Potential vulnerabilities are not the same as proven exploitation or impact on protected data.
Unapproved intrusive testing can create legal and availability harms; scope and rules of engagement must precede exploitation.
A point-in-time test cannot provide broad continuous asset and vulnerability coverage for the fleet.
A professional penetration test demonstrates one exploitable path into a representative application. What is the MOST important limitation when reporting assurance to leadership?
NIST SP 800-115 separates technical assessment techniques and their limits. Demonstrating one path does not establish exhaustive vulnerability coverage across all systems or times.
A demonstrated exploit applies to that tested path; unrelated scanner findings still need validation and prioritization.
Testing authority remains limited to approved scope and ownership regardless of discovered connectivity.
No finite test can prove the absence of all flaws, especially beyond its coverage and time window.
An assessment program claims it distinguishes potential technical weaknesses from proven attacker paths. Which deliverable BEST supports that claim?
The report communicates what was scanned, what was tested, what actually succeeded and what remains unproven, avoiding overstatement of assurance.
Raw detection inventory is not proof of tested exploit paths or business consequences.
An isolated demonstration without authorization and context does not support an accountable assessment program.
Absence of observed critical findings in one scope is not proof of complete security assurance.
A penetration tester proposes destructive exploit payloads against a production patient system without recovery plans. As the accountable security practitioner, which response BEST addresses the specific weakness without introducing a different untested control?
Testing value must be balanced against availability, privacy and patient safety risk. Isolated test results may not exactly represent production and need documented limitations.
A production test can create unacceptable patient-safety and availability harm.
Unbounded scope undermines safe and authorized security assessment.
Risk-sensitive testing can use safe methods or representative isolation rather than abandoning assurance.
The organization implemented the response to this scenario: A penetration tester proposes destructive exploit payloads against a production patient system without recovery plans. The approved response was: Use non-destructive tests or a representative isolated environment under approved safety constraints. Which statement MOST accurately identifies a remaining risk or constraint?
Testing value must be balanced against availability, privacy and patient safety risk. Approved tests demonstrate control behavior without damaging patient workflows.
Test environments may differ; limitations need explicit mapping to production risk.
Authorized assessment must still obey approved methods, timing and recovery rules.
Testing outcomes require business and operational impact evaluation beyond scanner completion.
Management implemented a response after this event: A penetration tester proposes destructive exploit payloads against a production patient system without recovery plans. The response was: Use non-destructive tests or a representative isolated environment under approved safety constraints. Which observed outcome BEST verifies that the intended security protection operates, rather than merely appearing in a plan?
Approved tests demonstrate control behavior without damaging patient workflows. Testing value must be balanced against availability, privacy and patient safety risk.
Successful exploitation is not a safe authorized assessment outcome.
A representative test needs explicit scope and limitations.
Finding counts do not replace availability and safety controls.
Internet-only vulnerability scanning shows no critical findings, but internal server package inventories reveal old vulnerable libraries accessible after authentication. What should the assessment plan add?
Unauthenticated network probes cannot inspect every installed package or internal setting. Credentialed assessment expands coverage but requires explicit authorization and credential custody.
A lack of external signatures does not prove current internal package or configuration state.
Scanner credentials are high-value assets and need proportionate privilege, storage and expiration.
Suppressed logging impairs accountability and does not improve the relevant vulnerability detection scope.
A company adds credentialed vulnerability scans to its server baseline. What associated security risk should the assessment owner explicitly manage?
Deeper scan visibility often uses powerful identities. Credential custody and narrowly authorized scope are necessary to avoid turning a defensive scanner into an attack platform.
Effective privilege may exceed a product label; real API and host permissions must be reviewed.
Distributing credentials increases compromise and removes individual accountability.
A completed assessment does not replace ongoing secret lifecycle and privilege monitoring.
An assessment program claims it detects package/configuration weaknesses missed by external scanners without granting broad permanent credentials. What evidence best supports the improvement?
The evidence verifies both increased assessment coverage and that the assessment process itself respects least privilege.
This confirms the original blind spot rather than eliminating it.
Coverage is improved at the cost of an excessive credential exposure inconsistent with the requirement.
Installation status does not prove detection efficacy or credential scope.
A vulnerability scanner reports a patched device as exploitable because the version banner did not change. What is the BEST assessment response?
A signature match can be a false positive; validation must establish affected code and reachable behavior.
False positives require triage rather than rejecting useful vulnerability detection.
An open ticket is not evidence of successful remediation.
Unsafe unapproved exploitation can cause business harm and is not required for every finding.
An analyst closes the banner-based finding after verifying a backported vendor patch. What future risk should be managed?
A point-in-time false positive decision is contingent on specific facts and controls.
Patch status and exposure vary across versions, instances and configurations.
Severity metadata does not establish observed compromise.
Traceable findings and justified decisions aid future reevaluation.
or Guarantee your success by buying the full version which covers the full latest pool of questions. (484 Questions, Last Updated on Oct 31, 2026)
Please check your mailbox for a message from support@examlabs.com and follow the directions.